A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 249
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : EBNA1
Long Form : Epstein-Barr nuclear antigen 1
No. Year Title Co-occurring Abbreviation
2020 Biophysical Screens Identify Fragments That Bind to the Viral DNA-Binding Proteins EBNA1 and LANA. EBV, KSHV, LANA, SPR, STD
2020 EBNA-1 titer gradient in families with multiple sclerosis indicates a genetic contribution. IgG, SNPs, VZV
2020 Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine model. EAE, EBNA-1, EBV, MBP, MS
2020 Genotypic Characterization of Epstein Barr Virus in Blood of Patients with Suspected Nasopharyngeal Carcinoma in Ghana. EBNA2, EBV, NPC
2020 Prolonged siRNA expression in mammalian cells using an Epstein-Barr virus-based plasmid expression system. oriP, RNAi, siRNAs
2020 Race-dependent differences in risk, genomics and Epstein-Barr virus exposure in monoclonal gammopathies: Results of SWOG S0120. AA, EA, GEP, MGUS, MM
2020 Recombinant Epstein-Barr virus glycoprotein 350 as a serological antigen. aa, EBV, gp350, VCA
2020 Targeting Epstein-Barr virus nuclear antigen 1 (EBNA-1) with Murraya koengii bio-compounds: An in-silico approach. EBNA-1, EBV
2020 Vitamin D, smoking, EBV, and long-term cognitive performance in MS: 11-year follow-up of BENEFIT. EBV, IgG, MS, NfL, PASAT
10  2019 Anti-C1q Antibodies as Occurring in Systemic Lupus Erythematosus Could Be Induced by an Epstein-Barr Virus-Derived Antigenic Site. EBV, SLE
11  2019 F factor plasmid-mediated Epstein-Barr virus genome introduction establishes an EBV positive NPC cell model. EBERs, EBV, LMP1, LMP2A, NPC, TEM
12  2019 Lentivirus-mediated RNA interference targeting EBNA1 gene inhibits the growth of GT-38 cells in vitro and in vivo. EBVaGC, RNAi, RT-qPCR, siRNA
13  2019 Novel Patterns of the Epstein-Barr Nuclear Antigen (EBNA-1) V-Val Subtype in EBV-associated Nasopharyngeal Carcinoma from Vietnam. EBV, nested-PCR, NPC
14  2019 Novel Synthetic DNA Immunogens Targeting Latent Expressed Antigens of Epstein-Barr Virus Elicit Potent Cellular Responses and Inhibit Tumor Growth. EBV, SynCon
15  2019 Reactivation of Epstein-Barr virus by a dual-responsive fluorescent EBNA1-targeting agent with Zn2+-chelating function. EBV
16  2019 Real time detection and quantification of Epstein Barr virus in different grades of oral gingivitis and periodontitis patients. EBV, HCMV
17  2019 Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication. DS, EBV, FR, oriP, oriP
18  2019 Structure-based design of small-molecule inhibitors of EBNA1 DNA binding blocks Epstein-Barr virus latent infection and tumor growth. EBV, NPC, TGF-beta
19  2019 [Epstein-Barr Virus Genome Replication as a Molecular Target for Cancer Therapy]. EBV
20  2018 Co-amplification of EBNA-1 and PyLT through dhfr-mediated gene amplification for improving foreign protein production in transient gene expression in CHO cells. CHO, PyLT, rCHO, TGE
21  2018 Co-Expression of the Epstein-Barr Virus-Encoded Latent Membrane Proteins and the Pathogenesis of Classic Hodgkin Lymphoma. cHL, EBERs, EBV
22  2018 EBNA1-targeted inhibitors: Novel approaches for the treatment of Epstein-Barr virus-associated cancers. EBV
23  2018 Epstein-Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus. EBV, KSHV, LANA, PEL
24  2018 Epstein-Barr virus- and cytomegalovirus-specific immune response in patients with brain cancer. CMV, CMV-pp65, EBV, IFN-gamma, IgG
25  2018 Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient. hESC, HS, LSD, MPSIIIB, NAGLU
26  2018 Lymphomas driven by Epstein-Barr virus nuclear antigen-1 (EBNA1) are dependant upon Mdm2. EBV
27  2018 Molecular mimicry, genetic homology, and gene sharing proteomic "molecular fingerprints" using an EBV (Epstein-Barr virus)-derived microarray as a potential diagnostic method in autoimmune disease. EBV
28  2018 Optimization of a high-cell-density polyethylenimine transfection method for rapid protein production in CHO-EBNA1 cells. CHO, TGE
29  2018 The Hsp70 inhibitor 2-phenylethynesulfonamide inhibits replication and carcinogenicity of Epstein-Barr virus by inhibiting the molecular chaperone function of Hsp70. EBV, HSP70, PES
30  2017 Analysis of DNA topology of EBV minichromosomes in HEK 293 cells. EBV, HEK, SV40
31  2017 Berberine inhibits the proliferation of human nasopharyngeal carcinoma cells via an Epstein-Barr virus nuclear antigen1-dependent mechanism. CCK-8, EBV, NPC
32  2017 Epstein-Barr virus infection and breast invasive ductal carcinoma in Egyptian women: A single center experience. EBV, IDC, IHC, LMP1
33  2017 Epstein-Barr virus, cytomegalovirus, and multiple sclerosis susceptibility: A multiethnic study. CIS, CMV, EBV, MS
34  2017 Evaluation of the presence of Epstein-Barr virus (EBV) in Iranian patients with thyroid papillary carcinoma. EBV, PTC
35  2017 Identification of Epstein-Barr Virus in the Human Placenta and Its Pathologic Characteristics. EBER-1, EBV
36  2017 Plasma Viral miRNAs Indicate a High Prevalence of Occult Viral Infections. EBV, ISH, RT-qPCR
37  2017 Structural basis for the regulation of nuclear import of Epstein-Barr virus nuclear antigen 1 (EBNA1) by phosphorylation of the nuclear localization signal. EBV, NLS
38  2017 Time correlation between mononucleosis and initial symptoms of MS. EBV, IM
39  2017 Transcriptome-wide analysis of alternative RNA splicing events in Epstein-Barr virus-associated gastric carcinomas. AS
40  2016 A pre-eclampsia-associated Epstein-Barr virus antibody cross-reacts with placental GPR50. PE
41  2016 Application of synthetic peptides for detection of anti-citrullinated peptide antibodies. ACPAs, RA
42  2016 Comparison of Circulating Tumour Cells and Circulating Cell-Free Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Undergoing Radiotherapy. cfDNA, CTCs, dPCR, EBV, NPC
43  2016 Computational analysis of EBNA1 "druggability" suggests novel insights for Epstein-Barr virus inhibitor design. EBV
44  2016 HCF1 and OCT2 Cooperate with EBNA1 To Enhance OriP-Dependent Transcription and Episome Maintenance of Latent Epstein-Barr Virus. Cp, EBV, HCF-1, HSV, HSV-1, IE, LCLs, MLL, Oct2, oriP, Qp
45  2016 Identification of Kaposi Sarcoma Herpesvirus (KSHV) vIRF1 Protein as a Novel Interaction Partner of Human Deubiquitinase USP7. ATM, HSQC, KSHV, USP7, USP7, vIRF1
46  2016 Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis. EBV, MS
47  2016 Regulatory T Cells in Endemic Burkitt Lymphoma Patients Are Associated with Poor Outcomes: A Prospective, Longitudinal Study. eBL, EBV
48  2016 Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients. CI, IgG
49  2015 Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study. CDMS, CIS, CSF, OCBs
50  2015 Development of a time-resolved fluorescence immunoassay for Epstein-Barr virus nuclear antigen 1-immunoglobulin A in human serum. ELISAs, TR-FIA
51  2015 EBNA1. ---
52  2015 EBV-Associated Cancer and Autoimmunity: Searching for Therapies. EBV
53  2015 Epstein-Barr virus and Interleukin-28B polymorphism in the prediction of response to interferon therapy in hepatitis C patients. EBV, ELISA, FUP, HCV, IgM, NRs, PCR, SVRs, VCA
54  2015 Epstein-Barr virus infection is equally distributed across the invasive ductal and invasive lobular forms of breast cancer. EBV
55  2015 Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment. AU, EBV, MS, VCA
56  2015 Frequency of Epstein--Barr virus infection as detected by messenger RNA for EBNA 1 in histologically proven gastric adenocarcinoma in patients presenting to a tertiary care center in South India. EBV, mRNA, PCR
57  2015 Gender influence in EBV antibody response in multiple sclerosis patients from Kuwait. EBV, MS, VCA
58  2015 The 3D structure of Kaposi sarcoma herpesvirus LANA C-terminal domain bound to DNA. DBD, KSHV, LANA, LBS1
59  2015 The V-val subtype Epstein-Barr virus nuclear antigen 1 promotes cell survival after serum withdrawal. EBV
60  2014 Adenovirus-based vaccines against rhesus lymphocryptovirus EBNA-1 induce expansion of specific CD8+ and CD4+ T cells in persistently infected rhesus macaques. EBV, HSV-gD, LCV, Rh
61  2014 Combined linkage and association studies show that HLA class II variants control levels of antibodies against Epstein-Barr virus antigens. EBV, HL, VCA
62  2014 DNA-based hybridization chain reaction for an ultrasensitive cancer marker EBNA-1 electrochemical immunosensor. CS, CV, DPV, GCE, GS, HCR, MWCNTs
63  2014 EBNA1 binding and epigenetic regulation of gastrokine tumor suppressor genes in gastric carcinoma cells. EBV, GC, GKN1, GKN2
64  2014 Efficient iPS cell generation from blood using episomes and HDAC inhibitors. EGFP, HDAC, hESC, iMEFs, iPSCs, PBMCs, sh
65  2014 Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides are cross recognized by anti-myelin basic protein antibodies in multiple sclerosis patients. MAP, MBP, MS
66  2014 Epstein-Barr virus in multiple sclerosis. EBV, IgG, MS, VCA
67  2014 Epstein-Barr virus nuclear antigen 1 (EBNA1) protein induction of epithelial-mesenchymal transition in nasopharyngeal carcinoma cells. EBV, EMT, miR-200a, NPC, ZEB1
68  2014 Human DNA tumor viruses generate alternative reading frame proteins through repeat sequence recoding. ARF, EBV, KSHV, LANA1
69  2014 Performance of the architect EBV antibody panel for determination of Epstein-Barr virus infection stage in immunocompetent adolescents and young adults with clinical suspicion of infectious mononucleosis. CI, CMV, EBV, IM, VCA
70  2014 [Construction and immunological responses of recombinant adenovirus containing Epstein-Barr nuclear antigen 1 in mice]. NPC, PCR
71  2013 A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1). EBV, HLA
72  2013 Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis. CMV, EA, EBV, HLA, HSV, MS, VCA
73  2013 CD4+ and CD8+ T-cell responses to latent antigen EBNA-1 and lytic antigen BZLF-1 during persistent lymphocryptovirus infection of rhesus macaques. EBV, rhBZLF-1, rhEBNA-1, rhLCV, TCM
74  2013 Enhanced and prolonged baculovirus-mediated expression by incorporating recombinase system and in cis elements: a comparative study. BV, hASCs, ori
75  2013 Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples. MS
76  2013 Identification of EBV infection in adults with egg specific food allergy. EBV, ELISA, VCA
77  2013 Ikappa B kinase alpha involvement in the development of nasopharyngeal carcinoma through a NF-kappaB-independent and ERK-dependent pathway. ERK, IKKalpha, MMPs, NF-kappaB, NPC, siRNA
78  2013 Potential cellular functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus. ---
79  2013 Slippery substrates impair ATP-dependent protease function by slowing unfolding. GAr, GRR
80  2012 Contributions of Epstein-Barr nuclear antigen 1 (EBNA1) to cell immortalization and survival. EBV
81  2012 E2F1, ARID3A/Bright and Oct-2 factors bind to the Epstein-Barr virus C promoter, EBNA1 and oriP, participating in long-distance promoter-enhancer interactions. Cp, EBV, FR, oriP
82  2012 Efficient expression and purification of tag-free Epstein-Barr virus EBNA1 protein in Escherichia coli by auto-induction. E. coli, EBV, TEV
83  2012 Epstein-Barr nuclear antigen 1 (EBNA1)-dependent recruitment of origin recognition complex (Orc) on oriP of Epstein-Barr virus with purified proteins: stimulation by Cdc6 through its direct interaction with EBNA1. ORC
84  2012 Epstein-Barr virus and multiple sclerosis: interaction with HLA. AP, CI, EBV, IM, MS, OR
85  2012 Expression profile of latent and lytic transcripts of epstein-barr virus in patients with gastroduodenal diseases: a study from northern India. EBV
86  2012 Homogeneous assay for detection of active Epstein-Barr nuclear antigen 1 by thrombin activity modulation. EBV, scssDNA
87  2012 Low vitamin D and elevated immunoreactivity against Epstein-Barr virus before first clinical manifestation of multiple sclerosis. CIS, EBV, IgG, MS
88  2012 Proteomic profiling of EBNA1-host protein interactions in latent and lytic Epstein-Barr virus infections. EBV, hnRNPs
89  2011 Epstein-Barr virus DNA load and its association with Helicobacter pylori infection in gastroduodenal diseases. EBV, GC, NUD, PUD
90  2011 Epstein-Barr Virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of survivin. ---
91  2011 Epstein-Barr virus nuclear antigen-1 B-cell epitopes in multiple sclerosis twins. EBV, ELISA, IM, MS, MZ
92  2011 Label free and amplified detection of cancer marker EBNA-1 by DNA probe based biosensors. 6-MHO, AP, EBV, QCM-D
93  2011 Prevalence of human herpesvirus 8 infection in systemic lupus erythematosus. EBV, EBV-VCA, EIA, HHV-8, SLE
94  2011 Vitamin D sensitive EBNA-1 specific T cells in the cerebrospinal fluid of patients with multiple sclerosis. CSF, MS
95  2011 [Effect of Epstein-Barr virus nuclear antigen 1 on cell proliferation and cell cycle in nasopharyngeal carcinoma cells]. CE, FACS, NPC, shRNA
96  2011 [Prediction and research on homology of B-cell epitopes of Epstein-Barr virus nuclear antigen-1]. ---
97  2010 Expression of Epstein-Barr nuclear antigen 1 in gastric carcinoma cells is associated with enhanced tumorigenicity and reduced cisplatin sensitivity. EBV
98  2010 Frequency and distribution of Epstein-Barr virus infection and its association with P53 expression in a series of primary nodal non-Hodgkin lymphoma patients from South India. ALCL, EBV, NHLs, PTCL
99  2010 Genome-wide analysis of host-chromosome binding sites for Epstein-Barr Virus Nuclear Antigen 1 (EBNA1). ChIP, ChIP-seq, EBV, oriP
100  2010 Human cytomegalovirus IE86 protein binds to cellular Mcm3 protein but does not inhibit its binding to the Epstein-Barr virus oriP in U373MG-p220.2 cells. EBV, HCMV, HFFs, MCM